V019-8663 Screening compound: 4-[6-butyl-3-(naphthalen-2-yl)-[1,2]oxazolo[5,4-d]pyrimidin-4-yl]-N-[3-(trifluoromethyl)phenyl]piperazine-1-carboxamide

V019-8663 Screening compound: 4-[6-butyl-3-(naphthalen-2-yl)-[1,2]oxazolo[5,4-d]pyrimidin-4-yl]-N-[3-(trifluoromethyl)phenyl]piperazine-1-carboxamide
V019-8663 Screening compound: 4-[6-butyl-3-(naphthalen-2-yl)-[1,2]oxazolo[5,4-d]pyrimidin-4-yl]-N-[3-(trifluoromethyl)phenyl]piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-8663
4-[6-butyl-3-(naphthalen-2-yl)-[1,2]oxazolo[5,4-d]pyrimidin-4-yl]-N-[3-(trifluoromethyl)phenyl]piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-8663

Molecular Formula

C31H29F3N6O2 (C31 H29 F3 N6 O2)

Compound Name

4-[6-butyl-3-(naphthalen-2-yl)-[1,2]oxazolo[5,4-d]pyrimidin-4-yl]-N-[3-(trifluoromethyl)phenyl]piperazine-1-carboxamide

IUPAC name

4-[6-butyl-3-(naphthalen-2-yl)-[12]oxazolo[54-d]pyrimidin-4-yl]-N-[3-(trifluoromethyl)phenyl]piperazine-1-carboxamide

SMILES

CCCCc1nc(onc2-c3cc4ccccc4cc3)c2c(N(CC2)CCN2C(Nc2cccc(C(F)(F)F)c2)=O)n1

InChI

InChI=1S/C31H29F3N6O2/c1-2-3-11-25-36-28(26-27(38-42-29(26)37-25)22-13-12-20-7-4-5-8-21(20)18-22)39-14-16-40(17-15-39)30(41)35-24-10-6-9-23(19-24)31(32,33)34/h4-10,12-13,18-19H,2-3,11,14-17H2,1H3,(H,35,41)

InChI Key

WSLJPXLRSSHWSQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19938101

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

574.61

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

7.899

Distribution Coefficient, logD

7.899

Water Solubility, LogSw

-6.58

Polar Surface Area

70.292

Acid Dissociation Constant (pKa)

11.62

Base Dissociation Constant (pKb)

4.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.00

V019-8663 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V019-8663 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-8663?
Check Price and Availability of V019-8663, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-8663 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-8663
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-8663
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-8663 available by request